Literature DB >> 25969497

The difficulty in diagnosing X linked adrenoleucodystrophy and the importance of identifying cerebral involvement.

Salil Patel1, Nicholas Gutowski2.   

Abstract

Two patients are described, a mother and son, who were initially clinically diagnosed with hereditary spastic paraparesis. This was rectified after very long chain fatty acid testing confirmed adrenomyeloneuropathy (AMN). The son's initial symptoms were characteristic of AMN (the commonest phenotype) but progressed to show symptoms of cerebral involvement. This evolution from non-cerebral to cerebral AMN is recognised in the medical literature and is increasingly important to consider in light of the availability of potential treatments such as haematopoietic stem cell transplantation. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25969497      PMCID: PMC4434265          DOI: 10.1136/bcr-2015-209732

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Long-term effect of bone marrow transplantation in adult-onset adrenoleukodystrophy.

Authors:  T Hitomi; T Mezaki; H Tomimoto; A Ikeda; S Shimohama; T Okazaki; T Uchiyama; H Shibasaki
Journal:  Eur J Neurol       Date:  2005-10       Impact factor: 6.089

2.  Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening.

Authors:  Prachi Dubey; Gerald V Raymond; Ann B Moser; Sidharth Kharkar; Lena Bezman; Hugo W Moser
Journal:  J Pediatr       Date:  2005-04       Impact factor: 4.406

3.  Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy.

Authors:  B M van Geel; L Bezman; D J Loes; H W Moser; G V Raymond
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

4.  X-linked adrenoleukodystrophy in women: a cross-sectional cohort study.

Authors:  Marc Engelen; Mathieu Barbier; Inge M E Dijkstra; Remmelt Schür; Rob M A de Bie; Camiel Verhamme; Marcel G W Dijkgraaf; Patrick A Aubourg; Ronald J A Wanders; Bjorn M van Geel; Marianne de Visser; Bwee T Poll-The; Stephan Kemp
Journal:  Brain       Date:  2014-01-29       Impact factor: 13.501

Review 5.  Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?

Authors:  Elena Galea; Nathalie Launay; Manuel Portero-Otin; Montserrat Ruiz; Reinald Pamplona; Patrick Aubourg; Isidre Ferrer; Aurora Pujol
Journal:  Biochim Biophys Acta       Date:  2012-02-12

6.  Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study.

Authors:  Björn M van Geel; Bwee Tien Poll-The; Aad Verrips; Jaap-Jan Boelens; Stephan Kemp; Marc Engelen
Journal:  J Inherit Metab Dis       Date:  2014-12-09       Impact factor: 4.982

Review 7.  Clinical and therapeutic aspects of adrenoleukodystrophy and adrenomyeloneuropathy.

Authors:  H W Moser
Journal:  J Neuropathol Exp Neurol       Date:  1995-09       Impact factor: 3.685

8.  X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.

Authors:  Marc Engelen; Stephan Kemp; Marianne de Visser; Björn M van Geel; Ronald J A Wanders; Patrick Aubourg; Bwee Tien Poll-The
Journal:  Orphanet J Rare Dis       Date:  2012-08-13       Impact factor: 4.123

9.  Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy.

Authors:  Jone López-Erauskin; Stéphane Fourcade; Jorge Galino; Montserrat Ruiz; Agatha Schlüter; Alba Naudi; Mariona Jove; Manuel Portero-Otin; Reinald Pamplona; Isidre Ferrer; Aurora Pujol
Journal:  Ann Neurol       Date:  2011-07       Impact factor: 10.422

10.  An under-recognised cause of spastic paraparesis in middle-aged women.

Authors:  D Bargiela; G Eglon; R Horvath; P F Chinnery
Journal:  Pract Neurol       Date:  2013-10-23
View more
  1 in total

1.  Management of X-linked adrenoleukodystrophy in Morocco: actual situation.

Authors:  F Z Madani Benjelloun; Y Kriouile; D Cheillan; H Daoud-Tetouani; L Chabraoui
Journal:  BMC Res Notes       Date:  2017-11-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.